---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-248694"
form_type: "8-K"
ticker: "EYPT"
cik: "0001314102"
company_name: "EyePoint, Inc."
filed_at: "2024-10-31T23:59:59+00:00"
generated_at: "2026-05-30T07:19:27.782172+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# EyePoint closes upsized $161M public offering; net proceeds ~$151.1M for DURAVYU development

## Summary
- Closed offering of 14,636,363 shares at $11.00/share, including full underwriter option exercise for 1,909,090 additional shares.
- Net proceeds of ~$151.1M after underwriting discounts and expenses; original offering was upsized from $125M to $161M gross.
- Proceeds to fund DURAVYU clinical development for wet AMD & DME, early-stage pipeline, and general corporate purposes.
- Joint book-runners: J.P. Morgan, Citigroup, Guggenheim Securities; co-managers: Baird, Mizuho, Jones.

## SEC filing metadata
- accession: 0001193125-24-248694
- form_type: 8-K
- ticker: EYPT
- cik: 0001314102
- company_name: EyePoint, Inc.
- filed_at: 2024-10-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1314102/000119312524248694/0001193125-24-248694-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1314102/000119312524248694/d904414d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-248694
- JSON: https://secwatch.observer/filing/0001193125-24-248694.json
- Plain text: https://secwatch.observer/filing/0001193125-24-248694.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.